Live tape
Top 8, mentions 7d10,913GOOGL2,081 mentions▲ +0.04SNDK1,536 mentions▲ +0.11SPCX1,501 mentions▲ +0.08NBIS1,429 mentions▲ +0.10HTZ1,239 mentions▲ +0.10NVDA1,212 mentions▲ +0.08META1,065 mentions▲ +0.03MSFT850 mentions▲ +0.06

Equity · Healthcare

MIRM

Mirum Pharmaceuticals, Inc. · NasdaqGM

$118.69 +1.09% 1D Finazon · prior-day close · Jul 17, 2026
Price · Chart
Our own end-of-day closes 40 sessions
$130 $90 20 May 17 Jul

The line runs $97.11 on 20 May through $118.69 on 17 July, on a scale from $90 to $130. Days the market did not trade hold the previous close, flat.

The chart above plots the price of MIRM over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 40 sessions over that window: $97.11 on 20 May 2026 through $118.69 on 17 July 2026.

Market cap $7.7B
52-week range $51 – $128
Avg volume 193.8K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 18, 2026

MIRM insider trades

SEC Form 4 · last 90 days · newest reported trade 11 Aug 2026
Open-market buys 0
Open-market sells 10
Net sold $10.16M
Non-trade filings 9
Date Insider Type Shares Value
11 Aug 2026 BJERKHOLT ERIC CHIEF FINANCIAL OFFICER Sell 6,001 $600K
10 Aug 2026 Peetz Christopher CHIEF EXECUTIVE OFFICER Sell 20,000 $1.98M
03 Aug 2026 Howe Jolanda SVP, GLOBAL CONTROLLER Sell 1,840 $194K
06 Jul 2026 BJERKHOLT ERIC CHIEF FINANCIAL OFFICER Sell 5,000 $611K
06 Jul 2026 Peetz Christopher CHIEF EXECUTIVE OFFICER Sell 20,000 $2.45M
01 Jul 2026 Howe Jolanda SVP, GLOBAL CONTROLLER Sell 2,721 $327K
17 Jun 2026 Howe Jolanda SVP, GLOBAL CONTROLLER Sell 2,594 $264K
08 Jun 2026 BJERKHOLT ERIC CHIEF FINANCIAL OFFICER Sell 5,000 $469K
01 Jun 2026 Ramasastry Saira Director Sell 3,977 $398K
01 Jun 2026 Peetz Christopher CHIEF EXECUTIVE OFFICER Sell 30,000 $2.88M

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
10 Aug 2026 Peetz Christopher CHIEF EXECUTIVE OFFICER Option exercise 20,000 $59K
06 Jul 2026 Peetz Christopher CHIEF EXECUTIVE OFFICER Option exercise 20,000 $59K
09 Jun 2026 BJERKHOLT ERIC CHIEF FINANCIAL OFFICER Option exercise 2,393 $63K
05 Jun 2026 Radovich Peter PRESIDENT AND COO Option exercise 16,988 $326K
01 Jun 2026 Peetz Christopher CHIEF EXECUTIVE OFFICER Option exercise 30,000 $88K
29 May 2026 Cardon Lon Director Option exercise 3,977
29 May 2026 Fischer Laurent Director Option exercise 3,977
29 May 2026 Walbert Timothy P Director Option exercise 3,977
29 May 2026 Ramasastry Saira Director Option exercise 3,977

MIRM reported financials

SEC EDGAR XBRL

MIRM reported revenue of $521.3M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$23.4M.

Figure Reported Period
Revenue $521.3M 31 Dec 2025 fiscal year
Net income −$23.4M 31 Dec 2025 fiscal year
Diluted EPS −$0.47 31 Dec 2025 fiscal year
Total assets $1.0B 30 Jun 2026 at period end
Total equity −$10.4M 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

MIRM earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $-1.06
31 Mar 2026 Q1 2026 $-13.43
31 Dec 2025 FY 2025 $-0.47
30 Sep 2025 Q3 2025 $0.05
30 Jun 2025 Q2 2025 $-0.12
31 Mar 2025 Q1 2025 $-0.30
31 Dec 2024 FY 2024 $-1.85
30 Sep 2024 Q3 2024 $-0.30

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

MIRM institutional holders

SEC Form 13F

9 of the 45 institutional funds we track reported a MIRM position for the quarter ended 30 Jun 2026 — a combined $273.9M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
Two Sigma Investments Held (±25%) −10.9% shares 690,318 $80.8M
Balyasny Asset Management Held (±25%) −9.3% shares 489,170 $57.3M
Baker Bros. Advisors Held (±25%) 445,975 $52.2M
Renaissance Technologies Held (±25%) −24.0% shares 442,185 $51.8M
Millennium Management Trimmed −73.9% shares 96,213 $11.3M
Fisher Asset Management Held (±25%) −11.4% shares 82,476 $9.7M
Man Group New position 37,183 $4.4M
AQR Capital Management Held (±25%) −9.9% shares 28,647 $3.4M
D. E. Shaw & Co. Trimmed −83.4% shares 27,879 $3.3M

Source: SEC EDGAR 13F filings

MIRM fails-to-deliver

SEC CNS data

On 31 Jul 2026, 72 shares of MIRM failed to deliver (about $8K).

Settlement date Shares failed Notional % of shares out
31 Jul 2026 72 $8K <0.001%
28 Jul 2026 226,091 $25.8M 0.348%
27 Jul 2026 228,372 $25.8M 0.352%
24 Jul 2026 241,590 $27.6M 0.372%
20 Jul 2026 58 $7K <0.001%
16 Jul 2026 21 $3K <0.001%
09 Jul 2026 899 $116K 0.001%
07 Jul 2026 2 $244 <0.001%

Source: SEC fails-to-deliver (CNS) data